37 related articles for article (PubMed ID: 34061795)
1. High Prevalence of Hepatitis C Virus among B-Cell Non Hodgkin Lymphoma Patients in Mansoura Region (Egypt), ANRS 12263 Study.
Saleh LM; Canioni D; Shamaa S; El-Zaafarany M; Emarah Z; Abdel-Aziz S; Eladle E; Abdelaziz A; Hermine O; Besson C; Abdel-Ghaffar H
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019011. PubMed ID: 30671217
[TBL] [Abstract][Full Text] [Related]
2. A Review on Analytical Strategies for the Assessment of Recently Approved Direct Acting Antiviral Drugs.
Aboras SI; Abdine HH; Ragab MAA; Korany MA
Crit Rev Anal Chem; 2022; 52(8):1878-1900. PubMed ID: 34138669
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis.
Jacobson IM; Lawitz E; Kwo PY; Hézode C; Peng CY; Howe AYM; Hwang P; Wahl J; Robertson M; Barr E; Haber BA
Gastroenterology; 2017 May; 152(6):1372-1382.e2. PubMed ID: 28193518
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection.
Kwo P; Gane EJ; Peng CY; Pearlman B; Vierling JM; Serfaty L; Buti M; Shafran S; Stryszak P; Lin L; Gress J; Black S; Dutko FJ; Robertson M; Wahl J; Lupinacci L; Barr E; Haber B
Gastroenterology; 2017 Jan; 152(1):164-175.e4. PubMed ID: 27720838
[TBL] [Abstract][Full Text] [Related]
5. Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
Bruchfeld A; Roth D; Martin P; Nelson DR; Pol S; Londoño MC; Monsour H; Silva M; Hwang P; Arduino JM; Robertson M; Nguyen BY; Wahl J; Barr E; Greaves W
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):585-594. PubMed ID: 28576451
[TBL] [Abstract][Full Text] [Related]
6. Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir.
Komatsu TE; Boyd S; Sherwat A; Tracy L; Naeger LK; O'Rear JJ; Harrington PR
Gastroenterology; 2017 Feb; 152(3):586-597. PubMed ID: 27773808
[TBL] [Abstract][Full Text] [Related]
7. Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.
Flamm SL; Bacon B; Curry MP; Milligan S; Nwankwo CU; Tsai N; Younossi Z; Afdhal N
Aliment Pharmacol Ther; 2018 Jun; 47(11):1511-1522. PubMed ID: 29665097
[TBL] [Abstract][Full Text] [Related]
8. Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection.
Sica A; Spada A; Sagnelli C; Verolino P; Mazzocca A; Sagnelli E; Colella G; Guastafierro S; Marrone A
Infez Med; 2021 Jun; 29(2):277-279. PubMed ID: 34061795
[TBL] [Abstract][Full Text] [Related]
9. Grazoprevir + elbasvir for the treatment of hepatitis C virus infection.
Alric L; Bonnet D
Expert Opin Pharmacother; 2016; 17(5):735-42. PubMed ID: 26933896
[TBL] [Abstract][Full Text] [Related]
10. Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4.
Al-Salama ZT; Deeks ED
Drugs; 2017 May; 77(8):911-921. PubMed ID: 28417245
[TBL] [Abstract][Full Text] [Related]
11. Elbasvir-grazoprevir: A new direct-acting antiviral combination for hepatitis C.
Karaoui LR; Mansour H; Chahine EB
Am J Health Syst Pharm; 2017 Oct; 74(19):1533-1540. PubMed ID: 28947524
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection.
Ahmed H; Abushouk AI; Menshawy A; Attia A; Mohamed A; Negida A; Abdel-Daim MM
Ann Hepatol; 2018; 17(1):18-32. PubMed ID: 29311409
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
